Ionis Pharmaceuticals, Inc. Convertible Debt, Noncurrent
Ionis Pharmaceuticals, Inc. (IONS) had Convertible Debt, Noncurrent of $596.36 million as of 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation › Long-Term Debt, Excluding Current Maturities
us-gaap:ConvertibleDebtNoncurrent · last filed 2019-11-06
- 2019-09-30: Convertible Debt, Noncurrent $596.36M.
- 2019-06-30: Convertible Debt, Noncurrent $586.80M.
- 2019-03-31: Convertible Debt, Noncurrent $577.41M.
- 2018-12-31: Convertible Debt, Noncurrent $568.22M.
| Period end | Convertible Debt, Noncurrent |
|---|---|
| 2019-09-30 | $596.36M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $586.80M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $577.41M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $568.22M 10-Q · filed 2019-11-06 |
| 2018-09-30 | $559.18M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $550.33M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $541.63M 10-Q · filed 2018-05-07 |
| 2017-12-31 | $533.11M 10-K · filed 2019-03-01 |
| 2017-09-30 | $524.74M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $516.54M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $508.41M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $500.51M 10-K · filed 2018-02-28 |
| 2014-09-30 | $155.44M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $153.70M 10-Q · filed 2014-08-04 |
| 2014-03-31 | $152.00M 10-Q · filed 2014-05-06 |
| 2013-12-31 | $150.33M 10-Q · filed 2014-11-07 |
| 2013-09-30 | $148.71M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $147.10M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $145.53M 10-Q · filed 2013-05-07 |
| 2012-12-31 | $143.99M 10-K · filed 2014-03-03 |
| 2012-09-30 | $142.50M 10-Q · filed 2012-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |